In Vivo Detection of Circulating Clots in Patients With Thromboembolism
ConditionThromboembolism
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Arkansas
About this trial
Subjects with thromboembolic disease or at high-risk for thromboembolic conditions diagnosed with ultrasound or other standard of care techniques will be recruited to estimate the feasibility of a device to detect in vivo CBCs.
Eligibility criteria
Qualifiers
Men and women, 18 years old and older.
Evidence of current venous or arterial thromboembolic disease diagnosed by standard of care clinical, radiographic, or laboratory testing or acute ischemic stroke.
Informed consent provided by the subject.
Disqualifiers
Pulmonary embolus with a need for mechanical ventilation or other ventilator support (may be on oxygen delivered by nasal cannula or mask at an FiO2 of ≤ 0.40)
Acute coronary syndrome (including unstable angina)
Significant cardiac arrhythmia (may have atrial fibrillation controlled with medication)
Intracardiac thrombus
Trial design
Treatments tested in this trial
- Photoacoustic Flow Cytometry
Treatment groups
30 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov